MobiHealth News May 27, 2025
The company will use the funds to grow its team, expedite commercial deployments with pharma companies and enhance Willis, its new clinical outcome assessment platform.
Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding.
The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio and Blue Falcon Capital.
WHAT IT DOES
Brooklyn Health measures mental health outcomes in clinical trial participants.
According to Brooklyn Health, central nervous system clinical trials depend heavily on clinical interviews as their primary outcome measure for treatment. The company says the interviews enable the scoring of symptoms via observation and are essential to measure variations in response to treatment.
In...
Today's Sponsors
Today's Sponsor